Science, Medicine and Technology

Cancer Breakthrough

08-13-2011 • arclein

Two of the three patients who received doses of the designer T cells in a clinical trial have remained cancer-free for more than a year, the researchers said. Experts not connected with the trial said the feat was important because it suggested th